Peking University People's Hospital

This study tested a drug called IBI311 in 53 people with thyroid eye disease that did not get better with steroids. The drug is a modified antibody that blocks a specific receptor. The main goal was to see if it could reduce eye bulging. The trial was completed and compared IBI31…

This study tested whether managing sleep apnea remotely with a breathing device (APAP) can lower blood pressure as well as traditional in-person care. Researchers enrolled 344 adults with suspected sleep apnea in Beijing. Participants were randomly assigned to either telemedicine…

This Phase 2 trial tested Proximod, a daily pill that calms the immune system, in 179 adults with moderate-to-severe rheumatoid arthritis who had not responded well to standard treatments. Participants took either 5 mg, 10 mg, or a placebo daily for three months, with one month o…

This phase 2 trial tested whether adding a PD-1 inhibitor (Sintilimab) after standard chemoradiotherapy could improve outcomes for 30 patients with locally advanced mid-low rectal cancer. Participants received radiation and chemotherapy, then three doses of Sintilimab, followed b…

This study looked at whether a three-month diet and exercise program before IVF could improve live birth rates in overweight and obese women. 197 women were randomly assigned to either the weight loss group or a control group. The goal was to see if losing weight beforehand leads…

This completed phase 3 trial tested whether adding all-trans retinoic acid (ATRA) to eltrombopag works better than eltrombopag alone for adults with immune thrombocytopenia (ITP) that did not respond to steroids. The study enrolled 96 participants and measured sustained platelet …

This study tested whether drinking an energy drink before a planned C-section keeps the mother as warm as using a warming mattress during surgery. 302 women having elective C-sections took part. The goal was to see which method better prevents a drop in body temperature during th…

This completed study looked at 314 people with blood cancers who received stem cell transplants from mismatched donors. Researchers tracked donor-specific antibodies after transplant to see how often they appear and what factors influence them. The goal is to better understand an…